Q-Bank Breakdown: Cardiogenic shock — Why Every Answer Choice Matters

Cardiogenic shock is one of those Step questions where the “right” answer is only half the game—the real points come from proving why the other choices are wrong. The vignette will hand you a crashing patient and five interventions; your job is to match physiology to management fast.

---

Clinical Vignette (Q-bank style)

A 68-year-old man with a history of hypertension and hyperlipidemia presents with severe chest pressure and dyspnea. He is diaphoretic and confused. Vitals: T 37°C, HR 122/min, BP 78/52 mm Hg, RR 28/min, SpO₂ 90% on room air. Exam shows cool, clammy extremities, delayed capillary refill, jugular venous distension, and bilateral crackles. ECG shows ST-segment elevations in leads V2–V5. Bedside ultrasound: markedly reduced LV systolic function.

Labs: lactate 5.2 mmol/L.
A pulmonary artery catheter is placed and shows: PCWP 26 mm Hg, cardiac index 1.6 L/min/m², SVR elevated.

Question: Which of the following is the most appropriate next step in management?

A. High-dose IV furosemide
B. IV norepinephrine and dobutamine
C. Large-volume IV normal saline bolus
D. IV sodium nitroprusside
E. IV alteplase (tPA)

---

Step 1: Diagnose Cardiogenic Shock Before You Treat It

This patient has classic cardiogenic shock due to acute MI:

• Hypotension (MAP low) + signs of end-organ hypoperfusion (confusion, cool clammy skin, high lactate)
• Pulmonary edema (crackles) and JVD → volume backing up
• Hemodynamics:
  • Low cardiac index (pump failure)
  • High PCWP (left-sided filling pressure elevated)
  • High SVR (compensatory vasoconstriction)

Hemodynamic pattern table (high-yield)

---

Correct Answer: B. IV norepinephrine and dobutamine

Why this is the best next step

In cardiogenic shock, the immediate priorities are:

1. Restore perfusion pressure (you can’t perfuse organs without MAP)
2. Improve forward flow (increase cardiac output)
3. Definitive treatment: urgent revascularization (PCI preferred) for MI-related shock

Norepinephrine is often the first-line vasopressor in cardiogenic shock because it:

• Strongly increases SVR via $\alpha_1$
• Provides some $\beta_1$ support
• Is less arrhythmogenic than dopamine (a common NBME/Step nuance)

Dobutamine is an inotrope that:

• Increases contractility via $\beta_1$ → raises cardiac output
• Mildly decreases SVR via $\beta_2$ (so you often pair it with a pressor if hypotensive)

Practical Step phrasing:

• If they’re cold and wet (congested + hypoperfused): pressor + inotrope, plus rapid reperfusion if MI.

High-yield add-on: “Cold vs Warm” HF profiles (quick triage mental model)

---

Why Every Other Answer Choice is Wrong (and what it would fit)

A. High-dose IV furosemide

Why it’s tempting: crackles + pulmonary edema = “diurese.”
Why it’s wrong right now: this patient is in shock. The immediate problem is low cardiac output and hypotension, not “too much fluid” in the tank.

• Aggressive diuresis can drop preload and further reduce cardiac output → worse hypotension
• In “cold & wet,” you stabilize hemodynamics first (pressors/inotropes), then carefully address volume

When furosemide is right:

• Acute decompensated HF with adequate perfusion (warm & wet) and stable blood pressure.

---

C. Large-volume IV normal saline bolus

Why it’s tempting: shock = “give fluids.”
Why it’s wrong: cardiogenic shock is pump failure, and he already has evidence of high filling pressures:

• PCWP 26 mm Hg (elevated)
• Pulmonary edema on exam

More fluids will worsen pulmonary edema and oxygenation without fixing the failing LV.

When fluids are right:

• Hypovolemic shock (hemorrhage, dehydration): low PCWP, flat neck veins
• Some cases of right ventricular infarct can be preload-dependent, but you’d expect clear lungs and RV findings (inferior MI pattern, hypotension with JVD but minimal crackles).

---

D. IV sodium nitroprusside

Why it’s tempting: afterload reduction can improve forward flow in some HF states.
Why it’s wrong: nitroprusside is a potent arterial/venous vasodilator → it drops SVR and BP, which is dangerous in someone already hypotensive (78/52).

Rule of thumb:

• Vasodilators (nitroprusside, nitroglycerin) are for hypertensive acute pulmonary edema or “warm & wet” patients who can tolerate decreased afterload.

High-yield pearl: Nitroprusside can cause cyanide toxicity (especially with prolonged infusion, renal dysfunction), presenting with metabolic acidosis, altered mental status.

---

E. IV alteplase (tPA)

Why it’s tempting: STEMI is present; “lyse the clot.”
Why it’s wrong in this vignette: With cardiogenic shock and STEMI, the preferred definitive management is emergent PCI when available. Fibrinolysis is typically for:

• STEMI when PCI is not available within the recommended time window (classically within ~120 minutes of first medical contact in many teaching frameworks)
• And when no contraindications exist

Also, tPA is not the immediate hemodynamic stabilizer here. This patient needs perfusion restored now (pressor/inotrope) while moving to definitive reperfusion.

Test-day nuance: If a question forces “best next step” and includes urgent PCI as an option, that often beats thrombolysis in an unstable STEMI patient—especially in shock.

---

What USMLE Loves You to Know About Cardiogenic Shock

Classic findings

• Cold, clammy skin (high SVR)
• Pulmonary edema, JVD
• S3 gallop (volume overload + systolic dysfunction)
• Low urine output, altered mental status
• Labs: elevated lactate, metabolic acidosis possible

Common causes (board favorites)

• Acute MI (most common)
• Acute decompensated systolic HF
• Papillary muscle rupture → acute severe MR (post-MI; loud systolic murmur + pulmonary edema)
• Ventricular septal rupture (harsh holosystolic murmur, shock)
• Fulminant myocarditis
• Life-threatening arrhythmia (VT/VF, complete heart block)

Management priorities (high-yield sequence)

1. Airway/oxygenation (pulmonary edema often requires positive pressure ventilation)
2. Vasopressor (often norepinephrine) to maintain MAP
3. Inotrope (e.g., dobutamine) if low output persists
4. Definitive therapy
   • Revascularization for MI (PCI)
   • Fix mechanical complications (surgery)
5. Consider mechanical circulatory support (IABP, Impella, VA-ECMO) in refractory cases (test questions may hint “despite pressors/inotropes”)

---

Rapid “Answer Choice” Pattern Recognition

• Crackles + JVD + hypotension + cold extremities → cardiogenic shock
• Treatment pair you should think of:
  • Norepinephrine (pressure) + dobutamine (pump)

If you can say out loud: “low CO, high PCWP, high SVR”, the rest of the question becomes elimination.

---

Key Takeaways (what to remember on exam day)

• Cardiogenic shock = pump failure → low CO with high PCWP and high SVR.
• Norepinephrine supports MAP; dobutamine improves contractility and output.
• Do not reflexively give fluids when PCWP is high and lungs are wet.
• Vasodilators are for “warm” patients with adequate BP—not for shock.
• In MI-related cardiogenic shock, stabilize hemodynamics and move toward urgent PCI.